ROIV
Roivant Sciences Ltd. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website roivant.com
- Employees(FY) 904
- ISIN BMG762791017
Performance
-3.13%
1W
+1.85%
1M
-3.28%
3M
+15.47%
6M
+7.66%
YTD
+21.75%
1Y
Profile
Roivant Sciences Ltd., a commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for inflammation and immunology areas. The company provides Vants, a model to develop and commercialize its medicines and technologies focusing on biopharmaceutical businesses, discovery-stage companies, and health technology startups. It develops VTAMA, a novel topical for the treatment of psoriasis and atopic dermatitis; batoclimab and IMVT-1402, the fully human monoclonal antibodies targeting the neonatal Fc receptor across various IgG-mediated autoimmune indications; and RVT-3101, an anti-TL1A antibody for ulcerative colitis and Crohn's disease. The company was founded in 2014 and is based in London, the United Kingdom.
Technical Analysis of ROIV 2024-12-10
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-12-03 07:00
- 2024-12-03 07:00
- 2024-12-02 18:00
- 2024-12-02 18:00
- 2024-11-19 06:05
- 2024-11-15 04:01
- 2024-11-12 07:00
- 2024-11-11 18:00
- 2024-11-11 07:04
- 2024-10-29 16:35
- 2024-10-29 04:35
- 2024-10-28 09:25
- 2024-10-27 21:25
- 2024-09-27 06:37
Daily – Vickers Top Buyers & Sellers for 09/27/2024(Argus Research)
- 2024-09-18 07:30
- 2024-09-17 19:30
- 2024-09-10 06:30
- 2024-09-10 06:30
- 2024-09-09 18:30
- 2024-09-09 18:30
- 2024-09-09 07:00
- 2024-09-08 19:00
- 2024-09-04 18:55
- 2024-08-22 07:03
- 2024-08-08 07:00
- 2024-08-07 19:00
- 2024-07-25 16:05
- 2024-07-25 04:05
- 2024-05-30 20:04
- 2024-05-30 07:00
Page 1 of 6
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.